NOVTU Novanta Inc.

60.99USD-5.31%Mkt Cap: —P/E: —

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internatio…

Key Statistics

Company
Market Cap—
Enterprise Value2.00B USD
Revenue (TTM)1.03B USD
Gross Profit435.28M USD
Net Income (TTM)53.83M USD
Revenue/Share26.45 USD
Last Price60.99 USD
Fiscal Year EndDec 2025
MR QuarterJul 2026
Employees3.0K
CountryUS
SectorTechnology
IndustryScientific & Technical Instruments
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA11.07
EV/Revenue1.95
P/S—
P/B1.51
EPS (TTM)—
EPS (Forward)—
52W Range
47.5746% of range76.95
52W High76.95 USD
52W Low47.57 USD
Profitability
Gross Margin44.39%
Oper. Margin11.50%
EBITDA Margin17.57%
Profit Margin5.49%
ROE4.10%
ROA2.98%
Growth
Revenue Growth10.30%
Earnings Growth150.00%
Cash Flow & Leverage
Operating CF64.06M USD
CapEx (TTM)15.63M USD
FCF Margin11.50%
FCF Yield—
Net Debt-433.05M USD
Net Debt/EBITDA-2.39
Balance Sheet
Debt/Equity0.23
Current Ratio4.57
Quick Ratio3.65
Book Value/Sh42.74 USD
Cash/Share19.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateAug 3, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float37.54M
Insiders0.00%
Institutions94.84%
Short Interest
Short Ratio4.9d
Shares Short52.05K
Short (prev mo.)52.00K
Technical
SMA 5062.46 (-2.4%)
SMA 20060.97 (+0.0%)
Beta1.73
S&P 52W Chg15.78%
Avg Vol (30d)35.97K
Avg Vol (10d)100.90K
Technical Indicators
RSI (14)48.5
MACD0.1163
MACD Signal-0.3303
MACD Hist.+0.4467
BB Upper64.24 USD
BB Middle60.46 USD
BB Lower56.67 USD
BB Width12.51%
ATR (14)1.832 USD
Vol Ratio (20d)0.10x